The products include OP-1 Implant, OP-1 Putty, Opgenra and Osigraft. The transaction also includes the sale of the manufacturing facility in Lebanon, N.H.
Read the Stryker release on the transaction.
Read other coverage on Stryker:
– Stryker Acquires Boston Scientific Corp.’s Neurovascular Business for $1.5B
– Stryker’s David Veino: In Support of Vertebroplasty
– Stryker Receives Two Subpoenas for Device Marketing
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
